AACR Results Of Single Agent Ibrutinib from Dr... - CLL Support

CLL Support

23,088 members39,648 posts

AACR Results Of Single Agent Ibrutinib from Dr. Wiestner of the NIH

bkoffman profile image
bkoffmanCLL CURE Hero
0 Replies

The press release of Dr. Wiestner of the NIH on the one year data on single agent ibrutinib with no other drugs to help in 17p del and > 65 patients, with my commentary: bkoffman.blogspot.com/2013/...

Bottom line: 94% event free survival at one year. WOW!

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

Dr. Wiestner on Combos and fixed duration ibrutinib (he doesn't like the idea) and a webinar with Dr. Byrd and me

Hi everyone, Dr. Wiestner always has a fresh perspective on CLL treatment, and my interview at ASH...

How Ibrutinib works over time

Hi, At ASH 2016 in San Diego, CA, I had the honor of once again interviewing Dr. Wiestner from the...

Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies

I have checked but apologies if this has been posted before. Published online June 13, 2019. Key...

Encouraging results from son of Ibrutinib studies (Acalabrutinib/Calquence)

In case you need any more persuasion that we are in exiting times for the future of CLL, read this...

Dr. Furman on the Diminishing Role of FCR

Hi, As we're getting ready to head to ASH this week, we wanted to post in response to a query that...